Literature DB >> 19512943

Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension.

John-Luis Moretti1, Sandra L Burke, Roger G Evans, Gavin W Lambert, Geoffrey A Head.   

Abstract

OBJECTIVE: We examined whether a specific increase in sympathetic nervous system (SNS) activity accounts for the enhanced depressor response to ganglion blockade in angiotensin II (AngII)-induced hypertension in rabbits or whether it reflects a general increased sensitivity of arterial pressure to vasodilatation.
METHODS: Rabbits were renal denervated or sham-operated and 2 weeks later AngII (50 ng/kg per min) infusion commenced. Mean arterial pressure (MAP) responses to ganglion blockade (pentolinium) and vasodilators nitroprusside and adenosine were measured 2-4 weeks later.
RESULTS: Basal MAP was 74 +/- 2 mmHg and maximum hypotensive responses to pentolinium, nitroprusside and adenosine were -17 +/- 2, -17 +/- 1 and -21 +/- 2 mmHg. AngII increased MAP similarly in intact and renal denervated rabbits (+25 +/- 4 mmHg and +31 +/- 4 mmHg, respectively). In intact rabbits, depressor responses to pentolinium were augmented by 75% during AngII infusion but responses to vasodilators also increased by 73-106% suggesting general augmentation of vascular reactivity rather than a specific increase in SNS neural activity. Consistent with this notion, total noradrenaline spillover was similar in normal and AngII-treated rabbits. In renal denervated rabbits, AngII enhanced depressor responses to vasodilators but not pentolinium, suggesting that sympathetic activity may be reduced by AngII hypertension when renal nerves are absent. In anaesthetized rabbits, methoxamine-induced decreases in hindlimb vascular conductance were greater in hypertensive than normotensive rabbits suggesting the presence of vascular hypertrophy of sufficient magnitude to explain increased responses to ganglion blockade and vasodilators.
CONCLUSION: Enhanced depressor responses to ganglion blockade in AngII hypertension do not reflect augmented SNS activity, but rather, augmented sympathetic vasoconstriction mediated by a vascular amplifier effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19512943     DOI: 10.1097/HJH.0b013e32832dd0d8

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

1.  Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension.

Authors:  Marcos T Kuroki; Pilar A Guzman; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-23       Impact factor: 4.733

2.  Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.

Authors:  Hiroyuki Kobori; Qi Fu; Steven D Crowley; Romer A Gonzalez-Villalobos; Ruy R Campos
Journal:  J Appl Physiol (1985)       Date:  2010-12

3.  Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension.

Authors:  L Gabriel Navar
Journal:  J Appl Physiol (1985)       Date:  2010-12

4.  Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension.

Authors:  S L Burke; R G Evans; G A Head
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

Review 5.  New approaches to quantifying sympathetic nerve activity.

Authors:  Sandra L Burke; Elisabeth Lambert; Geoffrey A Head
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

Review 6.  Factors Responsible for Obesity-Related Hypertension.

Authors:  Kyungjoon Lim; Kristy L Jackson; Yusuke Sata; Geoffrey A Head
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

7.  Norepinephrine-evoked salt-sensitive hypertension requires impaired renal sodium chloride cotransporter activity in Sprague-Dawley rats.

Authors:  Kathryn R Walsh; Jill T Kuwabara; Joon W Shim; Richard D Wainford
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-25       Impact factor: 3.619

8.  Sympathetic overactivity prevails over the vascular amplifier phenomena in a chronic kidney disease rat model of hypertension.

Authors:  Omar Z Ameer; Cara M Hildreth; Jacqueline K Phillips
Journal:  Physiol Rep       Date:  2014-11-20

9.  Direct conscious telemetry recordings demonstrate increased renal sympathetic nerve activity in rats with chronic kidney disease.

Authors:  Ibrahim M Salman; Divya Sarma Kandukuri; Joanne L Harrison; Cara M Hildreth; Jacqueline K Phillips
Journal:  Front Physiol       Date:  2015-08-04       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.